Brevan Howard Capital Management’s AvePoint AVPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Buy
151,109
+12,705
+9% +$131K 0.01% 798
2026
Q1
$1.32M Buy
138,404
+99,644
+257% +$1.12M 0.01% 764
2025
Q4
$538K Buy
38,760
+18,765
+94% +$259K 0.01% 1074
2025
Q3
$300K Sell
19,995
-33,766
-63% -$567K ﹤0.01% 1566
2025
Q2
$1.04M Sell
53,761
-16,198
-23% -$281K 0.01% 1048
2025
Q1
$1.01M Buy
69,959
+44,692
+177% +$751K 0.01% 493
2024
Q4
$417K Buy
+25,267
New +$384K ﹤0.01% 675

Other funds holding AVPT

Brevan Howard Capital Management's AVPT Position: Q2 2026 in Review

Brevan Howard Capital Management increased its AvePoint (AVPT) stake by 9.2% in Q2 2026, buying an estimated $131K and bringing the position to 151,109 shares worth $1.69M. The position accounts for 0.01% of the portfolio, ranked #798.

Brevan Howard Capital Management first reported a position in AVPT in Q4 2024 and has held it in 7 quarters since. 253 funds tracked by Wall St. Rank hold AVPT as of Q2 2026.

  • Brevan Howard Capital Management held 151,109 shares of AvePoint worth $1.69M as of Q2 2026.
  • Brevan Howard Capital Management bought 12,705 AvePoint shares in Q2 2026, an estimated $131K.
  • AvePoint made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #798 holding.
  • Brevan Howard Capital Management first reported a position in AvePoint in Q4 2024 and has held it in 7 quarters since.
  • 253 funds tracked by Wall St. Rank held AvePoint as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.